Hope for diabetes: CRISPR-edited cells pump out insulin in a person – and evade immune detection Summary In a medical first, researchers from Sana Biotechnology implanted CRISPR-edited pancreatic islet cells…
First CRISPR horses spark controversy: what’s next for gene-edited animals? Summary Scientists in Buenos Aires have produced the first horses with CRISPR–Cas9 edits aimed at increasing muscle and speed. The…
Author Correction: PPP2R1A mutations portend improved survival after cancer immunotherapy Summary This is an author correction to a Nature article originally published 2 July 2025 on the association between PPP2R1A…
Diabetes drug shows anti-ageing effects on chromosomes Summary The diabetes medication henagliflozin has been linked to increased telomere length in a clinical trial, suggesting a potential anti-ageing effect at the…
Nature goes inside the world’s largest ‘mosquito factory’ — here’s the buzz Summary Raising mosquitoes to fight disease sounds odd, but a large facility in Brazil breeds millions of Aedes…
Cyberattack forces Jaguar Land Rover to tell staff to stay at home Summary Jaguar Land Rover (JLR) has told factory and retail staff to stay at home after a cyberattack…
Publisher Correction: In situ light-field imaging of octopus locomotion reveals simplified control Summary This is a publisher correction published 05 September 2025 for the original research article “In situ light-field…
Qantas penalises executives for July cyberattack Summary Qantas has reduced short-term bonuses for its CEO and executive management by 15 percentage points after a July cyberattack that exposed the personal…
CISA orders federal agencies to patch Sitecore zero-day following hacking reports Summary Federal civilian agencies have until 25 September 2025 to patch CVE-2025-53690, a Sitecore vulnerability tied to use of…
‘SEO fraud-as-a-service’ scheme hijacks Windows servers to promote gambling websites Summary A previously unknown group tracked as GhostRedirector has compromised at least 65 Windows servers since August 2024 to run…
